Context Alzheimer disease (AD) is a major public health issue with a prediction of 12 million
Americans being affected by 2025 from the present 4 million. Molecular and genetic findings …

Alzheimer's disease (AD) is the most common neurodegenerative disease in the world. It is
classified as familial and sporadic. The dominant familial or autosomal presentation …

The risk of Alzheimer's disease (AD) is strongly determined by genetic factors and recent
genome-wide association studies (GWAS) have identified several genes for the disease risk …

This is the second part of a three-part review series reviewing the most important advances
in Alzheimer's disease (AD) research since 2010. This review covers the latest research on …

Alzheimer disease (AD) is the most common cause of dementia. In the past decade, many
advances in the understanding of the etiology of AD have been reported. Familial early …

Alzheimer's disease (AD) is the major cause of dementia in Western societies. It progresses
asymptomatically during decades before being belatedly diagnosed when therapeutic …

Being the most common cause of dementia, AD is a polygenic and neurodegenerative
disease. Complex and multiple factors have been shown to be involved in its pathogenesis …

Alzheimer's disease is the most common form of dementia and is the only top 10 cause of
death in the United States that lacks disease-altering treatments. It is a complex disorder …

Alzheimer's disease (AD), a progressive, degenerative disorder of the brain, is believed to
be the most common cause of dementia amongst the elderly. AD is characterized by the …

Alzheimer's disease (AD) is the most frequent neurodegenerative disease with more than 35
million people affected worldwide, and no curative treatment currently available. AD is highly …